NCT02652455 2025-08-19Combining PD-1 Blockade, CD137 Agonism and Adoptive Cell Therapy for Metastatic MelanomaH. Lee Moffitt Cancer Center and Research InstitutePhase EARLY_PHASE1 Completed11 enrolled
NCT00612664 2015-10-12Phase II, 2nd Line Melanoma - RAND MonotherapyBristol-Myers SquibbPhase 2 Completed158 enrolled